$Adaptimmune Therapeutics (ADAP.US)$ "ADAPTIMMUNE THERAPE...
$Adaptimmune Therapeutics (ADAP.US)$ "ADAPTIMMUNE THERAPEUTICS" IS "NOT" 🚫 "GOING TO" "REVERSE SPLIT" TO "REGAIN" "NASDAQ MINIMUM BID PRICE COMPLIANCE" BY THE ( DECEMBER 1, 2025 ) "DEADLINE"...
IT IS "TOO" "LATE" TO "SCHEDULE" AN "EXTRAORDINARY GENERAL MEETING", AND THEN AT THAT "MEETING" GET A "REVERSE SPLIT" "APPROVED", AND THEN "IMPLEMENT" THE "REVERSE SPLIT", AND THEN "CLOSE" "ABOVE" ( $1.00 ) FOR ( 10 ) "CONSECUTIVE" "DAYS" "BEFORE" THE ( DECEMBER 1, 2025 ) "DEADLINE"...
YET THE "NASDAQ HEARINGS PANEL" "APPROVED" "ADAPTIMMUNE THERAPEUTICS" "PLAN" TO "REGAIN" "NASDAQ MINIMUM BID PRICE COMPLIANCE" BY ( DECEMBER 1, 2025 )...
THE "ONLY" "THING" THIS "COULD" "MEAN" IS "ADAPTIMMUNE THERAPEUTICS" "WILL" BE "ACQUIRED" FOR "MORE" THAN ( $1.00 ) A "SHARE" "BEFORE" THE ( DECEMBER 1, 2025 ) "COMPLIANCE" "DEADLINE"
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Market Insights
Hot Topics
Trump's 'Taco deal' sparks market rebound : Market rebound sustainable ?
1. If tariffs pause, which sectors benefit first? 2. Trump's "threat-compromise" cycle normalizes—how to hedge across assets?
Moo Options Explorer
Apr 7 17:28
Weekly roundup: Tariff turmoil and recession fears dominate
SexytwistINV : not worth buying huh
102087836 : chart seems to b on an uptrend though